MedPath

APP-based Multifaceted Management After PCI

Not Applicable
Conditions
Percutaneous Coronary Intervention
Interventions
Other: APP-based multifaceted management
Registration Number
NCT03059784
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Brief Summary

High rates of recurrent cardiovascular events and readmission after percutaneous coronary intervention (PCI) are important issues. Guidelines emphasize rehabilitation and secondary prevention. But many patients are lack of effective management after PCI.This study is aimed to examine the effect of mobile application (APP)-based multifaceted management on the improvement of long-term care after PCI.

Detailed Description

This is a cluster-randomized controlled trial to evaluate the effect of APP-based multifaceted management strategy on improvement of long-term care for medication adherence,risk factor control, and reduction of adverse events, readmission rate and mortality after PCI.It includes knowledge education, medication reminder,advice provision, support to change lifestyle behaviors. The program is interactive between care provider and patients. A total of 20 wards will be randomly assigned to intervention or usual care.Anticipated 1100 patients after PCI will be participated in the trial. All the participants will be followed up until 12 months.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1100
Inclusion Criteria
  • patients who have received percutaneous coronary intervention and are discharged alive in the study centers;
  • patients who are able to use APP;
  • patients who provide informed consent.
Exclusion Criteria
  • patients who are not able to use APP;
  • dementia;
  • mental disturbed;
  • patients who are not willing to receive management and follow up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
interventionAPP-based multifaceted managementAPP-based multifaceted management, including sending education material, everyday medication reminder, giving risk factor control support, clinical support to patients after PCI through APP.
Primary Outcome Measures
NameTimeMethod
evidence-based medication adherence (the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications)at 12 months after PCI

the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications

Secondary Outcome Measures
NameTimeMethod
rate of systolic blood pressure achieving targetat 12 months after PCI

rate of systolic blood pressure achieving target based on guideline

readmission rate12 months after PCI

readmission rate after PCI

rate of LDL-C achieving targetat 12 months after PCI

rate of LDL-C achieving target based on guideline

© Copyright 2025. All Rights Reserved by MedPath